DrugPatentWatch Database Preview
Drugs in Development Information for Treosulfan
» See Plans and Pricing
What is the development status for investigational drug Treosulfan?
Treosulfan is an investigational drug.
There have been 37 clinical trials for Treosulfan.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2007.
The most common disease conditions in clinical trials are Leukemia, Myelodysplastic Syndromes, and Preleukemia. The leading clinical trial sponsors are medac GmbH, National Cancer Institute (NCI), and Fred Hutchinson Cancer Research Center.
Summary for Treosulfan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,970 |
| WIPO Patent Applications | 1,970 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 3 (2007-01-01) |
| Vendors | 29 |
Recent Clinical Trials for Treosulfan
| Title | Sponsor | Phase |
|---|---|---|
| Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Phase 2 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies | National Cancer Institute (NCI) | Phase 2 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies | Fred Hutchinson Cancer Research Center | Phase 2 |
Clinical Trial Summary for Treosulfan
Top disease conditions for Treosulfan
Top clinical trial sponsors for Treosulfan
US Patents for Treosulfan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
